Fundraising Fox
🦊/People
Sign in

Alice Newcombe-Ellis

Investor

Founding & General Partner at Ahren Innovation Capital · Board director at Cambridge Epigenetix

United Kingdom

Writes $100K – $5M checks · typically $1.5M

Find your path to Alice

37 people in our graph share verified history with Alice — schools, employers, funds. One of them is your warm intro.

David DelfassyunlockedAlice: together at Ahren Innovation Capital (2020–2024)
×11Alice: together at Ahren Innovation Capital

About

Alice Newcombe-Ellis builds and runs a science-first model, partnering as the commercial translator to Nobel laureates and Cambridge lab heads and securing leading Cambridge and UK academics as co-founding partners.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechClimate TechDeep TechHardwareRobotics

Board director at Cambridge Epigenetix

Intro paths

→

In turn, Alice can intro founders to Cambridge Epigenetix's investors below.

Cambridge Epigenetix's investors · 8

AhrenCambridge · since 2018Ahren Innovation CapitalCambridge, Cambridgeshire · since 2018GV (Google Ventures)Mountain View · $250K – $50M checks · since 2018New Science VenturesGreenwich · $2M – $8M checks · since 2018Sequoia CapitalMenlo Park · $4.4M – $214M checks · since 2018TemasekSingapore · since 2021Third PointNew York · since 2021Third Point VenturesMenlo Park · since 2018

Experience

  1. Ahren Innovation CapitalFounder & Managing Partnercurrent2017 — present

Deals · 1

Cambridge EpigenetixBoard seat

via Ahren Innovation Capital · filed May 2018 · $12.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at Ahren Innovation Capital

Alma Louise Donohoe
Promoter at Ahren Innovation Capital
Andy Parker
Founding Partner at Ahren Innovation Capital
Anuj Nanwani
Principal at Ahren Innovation Capital
David Novak
Advisor at Ahren Innovation Capital
Diego Alegría
Investment Analyst at Wollef Ventures
Eve Young
Head of Corporate Affairs and Branding at Tetragon Financial Group Limited
Jaime Díaz Torre
Associate at Glisco Partners
Janusz Marecki
AI Partner at Ahren Innovation Capital

Network6

Andy Parker
Founding Partner at Ahren Innovation Capital
Chiara Castelli
Investor at Moonstone Venture Capital
Joanna Green
Principal at Ahren Innovation Capital
John Daugman
Partner at Ahren Innovation Capital
Martin Rees
Partner at Ahren Innovation Capital
Oliver Hedaux
Principal at Ahren Innovation Capital

Investors connected to Alice in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alice Newcombe-Ellis?
Alice Newcombe-Ellis builds and runs a science-first model, partnering as the commercial translator to Nobel laureates and Cambridge lab heads and securing leading Cambridge and UK academics as co-founding partners.
Where does Alice Newcombe-Ellis work?
Alice Newcombe-Ellis is Founding & General Partner at Ahren Innovation Capital and Board director at Cambridge Epigenetix.
What does Alice Newcombe-Ellis invest in?
Alice Newcombe-Ellis invests in AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Robotics.
What check size does Alice Newcombe-Ellis write?
Alice Newcombe-Ellis typically writes checks of $100K – $5M.
What boards does Alice Newcombe-Ellis sit on?
Alice Newcombe-Ellis holds tracked board seats at Cambridge Epigenetix.
What companies has Alice Newcombe-Ellis invested in?
Investments tracked here include Adrestia Therapeutics, AI21 Labs, Ambi Robotics, Heirloom, New Culture, NU Quantum - company, Rockley Photonics, Rubedo Life Sciences, Zapata Quantum.
Where did Alice Newcombe-Ellis go to school?
Alice Newcombe-Ellis studied at University of Cambridge (Double First Class degree, Mathematics); Harvard Business School (Fulbright & Baker Scholar, MBA); University of Cambridge (Master’s in Mathematics & Astrophysics).

Same school